Maruzzo M, Poprach A, Buti S, Bamias A, Zakopoulou R, DE Giorgi U, Kucharz J, Formisano L, Buttner T, Zucali PA, Li H, Incorvaia L, Kopp RM, Messina C, Kopecky J, Fornarini G, Landmesser J, Rebuzzi SE, Nasso C, Fay AP, Bhuva D, Pinto A, Buchler T, Pichler R, Kanesvaran R, Soares A, Massari F, Monteiro FS, Dos Santos Filho IA, Porta C, Basso U, Santoni M. Real-world comparison of the effectiveness and safety of immune-based combinations in elderly patients with advanced renal cell carcinoma (ARON-1 study). Minerva Urol Nephrol. 2026 Apr; 78(2):210-221.

Rinehardt HN, Tracy ET, Paredes A, Beckhorn C, Leraas HJ, Fusco J, McKay KG, Kontchou NT, Kastenberg ZJ, Hoyt DW, Roach J, Myers EK, Cost NG, Mullapudi B, Marchese CR, Jensen AR, Lautz TB, Carter M, Dasgupta R, Lundstedt J, Brungardt JG, Talbot L, Davidoff AM, Murphy AJ, Aldrink JH, Mansfield S, Piche N, Le-Nguyen A, Lal DR, Craig BT, Schuh JM, Cromeens BP, Mannava S, Castle S, Lopez A, Mello K, Short J, Petroze RT, Rajavel S, Thompson GR, Mattei P, Rothstein DH, Fialkowski E, Fowler K, Martchenke N, Rich BS, Glick RD, Brown EG, Doyle K, Abril P, Seemann N, Davidson J, Wilson CA, Le HD, Joshi D, Stellon M, Ahmed T, Dimmer A, Ehrlich PF, Hammoud M, Williams K, Grant CN, Gorgy M, Polites SF, Debertin J, Cameron DB, Stetson A, Kim ES, Lee WG, Barkhordar A, Austin M, Coakley BA, Kahan A, Murphy JT, Pitonak M, Boehmer C, Malek MM. Outcomes and Surgical Management of Malignant Rhabdoid Tumor of the Kidney: A Report From the Pediatric Surgical Oncology Research Collaborative. Pediatr Blood Cancer. 2026 Jun; 73(6):e70296.

Gupta N, Toumazos K, Walker J, Cranford W, Feygin Y, Zack J, Strup SE, Hensley A, Kieran K, Cost NG, Sorge C, Hensley P, McLouth C, Buchanan AF. Survivorship After Kidney Cancer in Children, Adolescents, and Young Adults-What Is Causing Death and When? Urology. 2026 May; 211:77-83.

Xu H, Kapur P, Christie A, Nielsen AW, Perny A, Brandenburg O, Small C, Miyata J, Zhong H, Roberts C, Elias R, Tcheuyap V, Duarte C, van Bokhoven A, Panian J, Li H, Collier KA, Zynger D, Meza L, Beuselinck B, Agarwal N, Mortazavi A, Pal S, McKay R, Lam ET, Rajaram S, Brugarolas J. Determinants of pancreatic tropism in metastatic renal cell carcinoma. JCI Insight. 2026 Mar 09; 11(5).

Shah NJ, Sura S, Shinde R, Dai W, Wentworth C, Conkling P, Bupathi M, Vickery D, Perini R, Motzer RJ. Real-world treatment patterns and clinical outcomes among patients with metastatic renal cell carcinoma post immune-oncology and vascular endothelial growth factor receptor targeted therapies: A multicenter community oncology-based study. Urol Oncol. 2026 Apr; 44(4):110979.

Kopp RM, Massari F, Grande E, Schieber TJ, Ürün Y, Kopecký J, Molina-Cerrillo J, Basso U, Kucharz J, Büttner T, Pichler R, Fiala O, Myint ZW, Galli L, Buchler T, Rizzo M, Bolek H, Bourlon MT, Conteduca V, Pinto A, Rizzo A, Rosellini M, Roviello G, Zgura A, Mollica V, Partl A, Yildirim A, Akova U, Buti S, Monteiro FSM, Soares A, Porta C, Bilen MA, Li H, Santoni M. Real-world evidences on adjuvant Pembrolizumab for renal cell carcinoma: results from the multicenter real-world ARON-1 study. Cancer Immunol Immunother. 2025 Nov 14; 74(12):374.

Velasquez-Herrera T, Valverde P, Fuentes S, Peña A, Ortiz R, Calderon P, Montero M, Gattuso G, Blanco J, Arreola M, Fernandez-Pineda I, Metzger M, Luna-Fineman S, Wilimas J, Spreafico F. Second Generation of AHOPCA (Asociación de Hemato-Oncología Pediátrica de Centro América) Treatment Guidelines for Wilms Tumor: A Report of Outcomes. Pediatr Blood Cancer. 2026 Feb; 73(2):e32148.

Molina-Cerrillo J, Roviello G, Bourlon MT, Studentova H, Fiala O, Cerbone L, Kucharz J, Ansari J, Zeppellini A, Taha T, Buti S, Ürün Y, Scagliarini S, Li H, Sunela K, Park SH, Rizzo M, Zgura A, Chiari R, Seront E, Catalano M, Ghosn M, Filosa A, Soares A, Massari F, Monteiro FSM, Grande E, Porta C, Bracarda S, Santoni M. Toxicity-related immunotherapy discontinuation and outcome in patients with advanced renal cell carcinoma treated with immune-based combinations (ARON-1 study). Int J Cancer. 2026 Mar 01; 158(5):1396-1405.

Massari F, Rosellini M, Melichar B, Grande E, Bourlon MT, Li H, Fiala O, Park SH, Fita MJJ, Taha T, Molina-Cerrillo J, Santini D, de Liañ AG, Büttner T, Scagliarini S, Manneh Kopp R, Zeppellini A, Ghosn M, Conteduca V, Bölek H, Rizzo A, Ansari J, Mollica V, Zgura A, Filosa A, Yildirim A, Akova U, Monteiro FSM, Buti S, Soares A, Bilen MA, Ürün Y, Santoni M. Sarcomatoid Differentiation in Renal Cell Carcinoma: Clinical and Pathologic Heterogeneity and Outcomes With Immune Checkpoint Inhibitors-Data From the ARON-1 Study. JCO Glob Oncol. 2025 Oct; 11:e2500376.

Dabbas MR, Guer M, Musso G, Garofano G, Meagher MF, Puri D, Yuen KL, Capitanio U, Larcher A, Saitta C, Kim B, Karamcheti S, Baker BH, Saito K, Yasuda Y, Patil D, Briganti A, Salonia A, Fujii Y, Master V, Montorsi F, Derweesh IH. Predictors of Survival and Recurrence After Partial or Radical Nephrectomy in Women with Localized Renal Cell Carcinoma: A Multicenter Analysis. Clin Genitourin Cancer. 2026 Feb; 24(1):102460.